Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Brain Lang. 2019 May 7;194:46–57. doi: 10.1016/j.bandl.2019.04.006

Table 1.

Demographic and clinical characteristics of patients and controls: Mean (SD)

naPPA svPPA lvPPA bvFTD Controls
M/F 2/7 7/4 7/7 9/5 13/23
Education (y) 13.9 (1.9) 15.2 (3.0) 16.0 (3.4) 16.3 (3.0) 15.9 (2.5)
Age at Time 1 66.1 (9.0) 61.0 (8.1) 64.9 (7.8) 67.1 (9.9) 69.1 (7.7)
Age at Time 2 67.5 (9.3) 63.9 (9.1) 67.0 (7.8) 69.4 (10.2) --
Time 1-Time 2 interval (months) 16.9 (7.2) 34.7 (26.2) 25.3 (14.1) 27.2 (19.3) --
Disease duration at Time 1 (y) 2.3 (0.7) 3.4 (2.0) 3.6 (2.3) 4.1 (3.1)
Disease duration at Time 2 (y) 3.8 (0.8) 6.3 (2.2) 5.7 (3.0) 6.5 (2.7)
MMSE, Time 1 23.6 (6.2)* 25.0 (3.2)* 25.3 (4.2)* 26.7 (2.6)* 29.1 (1.1)
MMSE, Time 2 18.7 (9.3)*# 15.8 (6.0)*#^ 20.5 (7.3)*# 24.9 (4.1)*#

Notes:

* Differs from Controls, p<.01

# Differs from corresponding Time 1, p<.05

^ svPPA differs from lvPPA (p<.05) and from bvFTD (p<.01)